Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.

Somedeb BallTodd C KnepperYehuda E DeutschWassim SamraJustin M WattsTerrence J BradleyOnyee ChanMohammad Omar HussainiLing ZhangKendra L SweetAndrew T KuykendallChetasi TalatiEric PadronRami S KomrokjiJeffrey E LancetDavid A Sallman

Published in: Cancer (2022)

Targetable mutations are frequent in EM-AML and EM-site NGS is warranted for selecting potential targeted therapies for patients with EM-AML.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
rna seq
gene expression
risk assessment